Please login to the form below

Not currently logged in
Email:
Password:

drug pricing

This page shows the latest drug pricing news and features for those working in and with pharma, biotech and healthcare.

Healthcare sector bullish, despite political uncertainty

Healthcare sector bullish, despite political uncertainty

transition. Across the Atlantic the big topic has been drug pricing, but despite the rhetoric coming out of the White House, most of the those polled (92%) do not think there ... Drug prices are expected to keep rising, but at a muted pace, ”says the

Latest news

  • MPs threaten to publish Vertex’s Orkambi price if no deal struck MPs threaten to publish Vertex’s Orkambi price if no deal struck

    Vertex has been attempting to gain reimbursement for its combination treatment Orkambi since 2016, but saw the drug rejected by cost effectiveness watchdog NICE that year. ... system. However this unprecedented involvement of the committee in the

  • Democrats regain control of House in mid-terms Democrats regain control of House in mid-terms

    direct-to-consumer (DTC) drug advertising. ... ahead of the midterms that a Democrat-controlled House and Republican Senate “will maintain the political stalemate status quo, making further implementation of Trump’s drug pricing blueprint more

  • Amgen CEO says Aimovig is “one of most successful launches” Amgen CEO says Aimovig is “one of most successful launches”

    Contrasts with cholesterol drug Repatha, its price slahed 60% to lift take-up. ... The Repatha discount comes as the US administration is ramping up the pressure on the biopharma industry on drug pricing, most recently proposing a reference pricing model

  • US says medicine ads should include list prices US says medicine ads should include list prices

    US says medicine ads should include list prices. Hopes the proposal will encourage lower prescription drug prices. ... Azar told the National Academy of Medicine (NAM) that “for too long, drug pricing has been like no other market.

  • Health secretary’s ‘rip off’ remarks anger UK pharma Health secretary’s ‘rip off’ remarks anger UK pharma

    Negotiations over the pricing and reimbursement for the drug have been going on for two years, with both sides claiming they have made exceptional offers. ... they need instead to accept the deal and supply the drug right now.”.

More from news
Approximately 56 fully matching, plus 202 partially matching documents found.

Latest Intelligence

  • Trust me, I’m from pharma Trust me, I’m from pharma

    However, controversies around drug pricing – fuelled by the unhelpful interventions of Martin Shkreli as the pin-up boy for big, bad pharma – have undermined progress and reinforced the view that the ... Individual companies are doing their bit too.

  • Patient outcomes in practice: delivering value that transforms lives Patient outcomes in practice: delivering value that transforms lives

    Providers, payers and manufacturers all have a role in achieving value, with increasing ethical pressure on drug pricing and resultant innovative, outcomes-based pricing models.

  • Drug pricing

    Healthcare terms - Drug pricing.

  • Healthcare Glossary

    Double-blind trial. A clinical trial design in which neither the participating individuals nor the study staff know which participants are receiving the experimental drug and which are receiving either placebo ... Double-blind trials are thought to

  • Risky business for pharma Risky business for pharma

    Chan Lee, North America general counsel, Sanofi, explained: “Drug pricing is a significant risk in our industry, particularly in the US.”Lee also cited “scrutiny of manufacturer interactions with payers, patients, ... PD Villareal, senior vice

More from intelligence
Approximately 7 fully matching, plus 29 partially matching documents found.

Latest appointments

  • Pfizer’s Emms takes up ABPI presidency Pfizer’s Emms takes up ABPI presidency

    Emms is no stranger to these issues, having served on the ABPI board and taken part in the negotiations over the future of drug pricing in the UK. ... He has not been afraid to criticise the outcomes of these discussions too, saying in November that the

  • Bayer's Martin Hesse moves to Daiichi Sankyo Europe

    Commenting on the environment in which he starts at Daiichi, Hesse said securing the company's profitability and competitiveness in the light of drug pricing interventions will a major challenge. “

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • A roadmap to strategic drug pricing

    A roadmap to strategic drug pricing. The current unit-based pricing model for drugs is too one-dimensional for the market's present needs. ... A roadmap to strategic drug pricing.

  • Pricing's Point Man

    Pricing's Point Man. In the wake of the publication of the second edition of 'The Price of Global Health', Ed Schoonveld talks to William Looney.

  • EY Life Sciences

    A roadmap to strategic drug pricing. ... In 2016, a renewed focus on value-based drug pricing, staunch competition across key therapeutic battlegrounds and consolidated payer clout may exacerbate existing growth gaps, resulting in a continued feverish

  • Ed Schoonveld - new article

    Ed Schoonveld - new article. Following the publication of the new edition of The Price of Global Health, Ed Schoonveld writes about the industry's need for new drug pricing model. ... Does the drug industry need a new pricing model? Read Ed Schoonveld's

  • The Price of Global Health

    Drug Pricing Strategies to Balance Patient Access and the Funding of Innovation.

More from PMHub
Approximately 4 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics